Stevanato [STVN] vs Intuitive Surgical [ISRG] Detailed Stock Comparison
Stevanato
NYSE
Loading...
Intuitive Surgical
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Stevanato wins in 8 metrics, Intuitive Surgical wins in 11 metrics, with 0 ties. Intuitive Surgical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Stevanato | Intuitive Surgical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 47.30 | 67.60 | Stevanato |
| Price-to-Book Ratio | 4.83 | 9.71 | Stevanato |
| Debt-to-Equity Ratio | 27.86 | 0.00 | Intuitive Surgical |
| PEG Ratio | 41.78 | 61.50 | Stevanato |
| EV/EBITDA | 29.87 | 52.75 | Stevanato |
| Profit Margin (TTM) | 11.16% | 28.51% | Intuitive Surgical |
| Operating Margin (TTM) | 13.97% | 30.47% | Intuitive Surgical |
| EBITDA Margin (TTM) | 13.97% | 30.47% | Intuitive Surgical |
| Return on Equity | 9.14% | 16.04% | Intuitive Surgical |
| Return on Assets (TTM) | 4.88% | 9.02% | Intuitive Surgical |
| Free Cash Flow (TTM) | $-157.80M | $1.30B | Intuitive Surgical |
| 1-Year Return | 17.95% | 2.29% | Stevanato |
| Price-to-Sales Ratio (TTM) | 6.08 | 18.95 | Stevanato |
| Enterprise Value | $8.44B | $168.05B | Intuitive Surgical |
| EV/Revenue Ratio | 6.48 | 18.38 | Stevanato |
| Gross Profit Margin (TTM) | 27.24% | 66.31% | Intuitive Surgical |
| Revenue per Share (TTM) | $4 | $26 | Intuitive Surgical |
| Earnings per Share (Diluted) | $0.53 | $7.15 | Intuitive Surgical |
| Beta (Stock Volatility) | 0.55 | 1.60 | Stevanato |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Stevanato vs Intuitive Surgical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Stevanato | -2.69% | -2.06% | -0.62% | 11.01% | 10.35% | 8.13% |
| Intuitive Surgical | 0.09% | -2.34% | -12.14% | -12.37% | -19.41% | -10.35% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Stevanato | 17.95% | 32.00% | 22.27% | 22.27% | 22.27% | 22.27% |
| Intuitive Surgical | 2.29% | 98.88% | 107.77% | 705.27% | 1,251.37% | 5,591.00% |
Performance & Financial Health Analysis: Stevanato vs Intuitive Surgical
| Metric | STVN | ISRG |
|---|---|---|
| Market Information | ||
| Market Cap | $6.84B | $173.27B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 494,099 | 2,569,790 |
| 90 Day Avg. Volume | 329,046 | 1,960,720 |
| Last Close | $23.55 | $470.23 |
| 52 Week Range | $17.12 - $28.00 | $425.00 - $616.00 |
| % from 52W High | -15.89% | -23.66% |
| All-Time High | $36.30 (Aug 07, 2023) | $616.00 (Jan 20, 2025) |
| % from All-Time High | -35.12% | -23.66% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.09% | 0.21% |
| Quarterly Earnings Growth | 0.41% | 0.25% |
| Financial Health | ||
| Profit Margin (TTM) | 0.11% | 0.29% |
| Operating Margin (TTM) | 0.14% | 0.30% |
| Return on Equity (TTM) | 0.09% | 0.16% |
| Debt to Equity (MRQ) | 27.86 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $5.19 | $49.79 |
| Cash per Share (MRQ) | $0.33 | $14.86 |
| Operating Cash Flow (TTM) | $213.29M | $2.83B |
| Levered Free Cash Flow (TTM) | $-131,513,802 | $1.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | $0.00 | N/A |
Valuation & Enterprise Metrics Analysis: Stevanato vs Intuitive Surgical
| Metric | STVN | ISRG |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 47.30 | 67.60 |
| Forward P/E | 41.78 | 61.50 |
| PEG Ratio | 41.78 | 61.50 |
| Price to Sales (TTM) | 6.08 | 18.95 |
| Price to Book (MRQ) | 4.83 | 9.71 |
| Market Capitalization | ||
| Market Capitalization | $6.84B | $173.27B |
| Enterprise Value | $8.44B | $168.05B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.48 | 18.38 |
| Enterprise to EBITDA | 29.87 | 52.75 |
| Risk & Other Metrics | ||
| Beta | 0.55 | 1.60 |
| Book Value per Share (MRQ) | $5.19 | $49.79 |
Financial Statements Comparison: Stevanato vs Intuitive Surgical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | STVN | ISRG |
|---|---|---|
| Revenue/Sales | $256.60M | $2.44B |
| Cost of Goods Sold | $186.71M | $822.10M |
| Gross Profit | $69.89M | $1.62B |
| Research & Development | $5.93M | $313.30M |
| Operating Income (EBIT) | $34.63M | $743.40M |
| EBITDA | $55.55M | $898.70M |
| Pre-Tax Income | $35.11M | $832.10M |
| Income Tax | $8.60M | $167.90M |
| Net Income (Profit) | $26.51M | $664.20M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | STVN | ISRG |
|---|---|---|
| Cash & Equivalents | $90.72M | $2.57B |
| Total Current Assets | $845.47M | $7.66B |
| Total Current Liabilities | $463.26M | $1.54B |
| Long-Term Debt | $312.73M | N/A |
| Total Shareholders Equity | $1.42B | $17.21B |
| Retained Earnings | $890.85M | $7.14B |
| Property, Plant & Equipment | $110.62M | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | STVN | ISRG |
|---|---|---|
| Operating Cash Flow | $100.69M | $833.10M |
| Capital Expenditures | $-69.33M | $-116.60M |
| Free Cash Flow | $28.05M | $465.00M |
| Debt Repayment | $-55.75M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | STVN | ISRG |
|---|---|---|
| Shares Short | 2.17M | 3.87M |
| Short Ratio | 7.35 | 2.37 |
| Short % of Float | 0.04% | 0.01% |
| Average Daily Volume (10 Day) | 494,099 | 2,569,790 |
| Average Daily Volume (90 Day) | 329,046 | 1,960,720 |
| Shares Outstanding | 272.90M | 356.60M |
| Float Shares | 48.81M | 356.33M |
| % Held by Insiders | 0.02% | 0.01% |
| % Held by Institutions | 1.11% | 0.89% |
Dividend Analysis & Yield Comparison: Stevanato vs Intuitive Surgical
| Metric | STVN | ISRG |
|---|---|---|
| Last 12-Month Dividend | $0.00 | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | $0.04 | N/A |
| 3-Year Avg Dividend Yield | 0.26% | N/A |
| 3-Year Total Dividends | $0.12 | N/A |
| Ex-Dividend Date | Jun 04, 2024 | N/A |